#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leber's congenital amaurosis Congenital growth hormone deficiency Breast angiosarcoma Focal segmental glomerulosclerosis Scleroderma associated digital ulcer Fungal infection Neurofibroma Lymphoma Neurodegenerative disorder Primary myelofibrosis Transient ischaemic attack Blood iron increased Haematological malignancy Follicle centre lymphoma follicular grade I II – III refractory Cutaneous T-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Diagnostics Haemophilia B without inhibitors – Trials in Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease Factor VIII deficiency – Trials in Disease Angiosarcoma – Basic Information Glomerulonephritis membranoproliferative Kearns-Sayre syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Treatment Rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cytarabine Glimepiride Propranolol WEF-001 Methotrexate Sodium ANOC-001 Anifrolumab Monalizumab ZINC Fludarabine Phosphate Ph. Eur. LTG-001 Ttf-Ngr Chloroprocaine Hydrochloride LUTETIUM LU-177 Tx200-Tr101 Folinic Acid Eteplirsen Dabrafenib Al8326 Ribonucleic Acid More therapies…

    Learn about Your Condition

    Relapsing multiple sclerosis Acarodermatitis Medulloblastoma recurrent Procedural headache K-ras gene mutation Epiphysiolysis Type 2 diabetes mellitus Bile duct adenocarcinoma Anxiety disorder Pustular psoriasis Peripheral spondyloarthritis B-cell lymphoma refractory Complex regional pain syndrome Endocarditis bacterial Bone metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praxis Reinfeld Mitte

Praxis Reinfeld Mitte

Paul-von-Schoenaich-Straße 29, Reinfeld, 23858, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study of ExPEC9V vaccine for preventing invasive E.

    Not recruiting

    3 1
    Investigated Drugs:
    • Ecoo15
    • Ecoo16
    • Ecoo18A
    Czechia Denmark France Germany The Netherlands Spain +1

  • Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Inclisiran
    • Rosuvastatin
    Bulgaria Czechia Estonia France Germany Latvia +2

  • Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Back pain
    Investigated Drugs:
    • Dronabinol
    • Ibuprofen
    • Pantoprazole
    Czechia Germany Poland Spain

  • Study on the Effects and Safety of ODM-111 and Paracetamol for Chronic Knee Pain in Osteoarthritis Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Arthralgia
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Czechia Denmark Germany Poland Spain

  • Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    • Pain
    Investigated Drugs:
    • Odm-111
    • Paracetamol
    Bulgaria Czechia Germany Hungary Poland

  • Efficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes

    Not recruiting

    3 1
    Bulgaria Czechia Germany Hungary Poland Romania +2

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!